A review study on the role of Avarana in the clinical presentation and pathogenesis of metabolic diseases

  • Garima Sisodiya Post Graduate Scholar, Department of Rog Nidan Evum Vikruti Vigyan, Pt. Khushilal Sharma Govt. (Autonomous) Ayurveda College and Institute, Bhopal, Madhya Pradesh, India. https://orcid.org/0009-0004-0580-4726
  • Rita Singh Reader & HOD, Department of Rog Nidan Evum Vikruti Vigyan, Pt. Khushilal Sharma Govt. (Autonomous) Ayurveda College and Institute, Bhopal, Madhya Pradesh, India.
Keywords: Avarana, metabolic disorders, Vata, obstruction, integrative medicine

Abstract

The Ayurvedic principle of Avarana, which describes the obstruction of Vata’s natural movement by another Dosha or Dhatu, provides a comprehensive lens through which various metabolic disorders now increasingly common globally and in India can be interpreted. In this review, classical sources were systematically examined alongside modern biomedical literature following SANARA guidelines to elucidate how Avarana mechanisms map onto contemporary pathophysiology. Distinct obstruction patterns were identified: in diabetes mellitus and obesity, Kapha and Meda obstruct Vyana and Samana Vata, correlating with insulin resistance and adiposity; in hypertension, Pitta’s encroachment upon Prana Vata parallels autonomic imbalance; in non-alcoholic fatty liver disease, excess Kapha envelops Doṣhivisha, mirroring hepatic steatosis and inflammation; hypothyroidism reflects Kapha’s blockade of Udana Vata, akin to slowed metabolism; In gout, the diseased state develops as aggravated Rakta blocks the movement of Vyana Vata, which parallels the pathological process of elevated uric acid levels and subsequent crystal accumulation in joints; and irritable bowel syndrome embodies mutual obstruction between Samana and Apana Vata, corresponding to dysregulated gut motility. This integrative analysis underscores the value of Avarana in offering personalized diagnostic and therapeutic strategies herbal formulations to remove obstructions, targeted Panchakarma procedures to restore Doshic balance, and lifestyle modifications tailored to the specific Dosha interactions. By bridging classical Ayurvedic theory with modern biomedical insights, this work proposes a nuanced, patient-centric approach for the prevention and management of metabolic disorders, advocating further clinical studies to validate Avarana-guided interventions.

Downloads

Download data is not yet available.

References

Arathi, D., Gopikrishna, S., & Saranya, K. (2023). Critical review on Avarana with contemporary understanding. AYUSHDHARA, 10(Suppl1), 7782. https://doi.org/10.47070/ayushdhara.v10iSuppl1.1137

Acharya Yadavji Trikamji. Susruta Samhita (Sutrasthana). Varanasi: Chaukhamba Sanskrit Sansthan; 2019. p.99.

Bhishagacharya Harisastri Paradakara Vaidya. Ashtanga Hrudayam (Sutrasthana). Varanasi: Chaukhamba Orientalia; 2011. p.9.

Yadavji Trikamji Acharya. Charaka Samhita (Sutrasthana). Varanasi: Chaukhamba Sanskrit Sansthan; 2021. p.114.

Pandit Sarangadhara Acharya. Sarangadhara Samhitha (PrathAma Khanda). Varanasi: Chaukhamba Orientalia; Reprint 2012. p.50.

Yadavji Trikamji Acharya. Charaka Samhita (Chikitsa Sthana). Varanasi: Chaukhamba Sanskrit Sansthan; 2021. p.616.

Bhishagacharya Harisastri Paradakara Vaidya. Ashtanga Hrudayam (Sutrasthana). Varanasi: Chaukhamba Orientalia; 2011. p.193.

Yadavji Trikamji Acharya. Charaka Samhita (Chikitsa Sthana). Varanasi: Chaukhamba Sanskrit Sansthan; 2021. p.626.

Yadavji Trikamji Acharya. Charaka Samhita (Chikitsa Sthana). Varanasi: Chaukhamba Sanskrit Sansthan; 2021. p.626.

Yadavji Trikamji Acharya. Charaka Samhita (Chikitsa Sthana). Varanasi: Chaukhamba Sanskrit Sansthan; 2021. p.626.

Yadavji Trikamji Acharya. Charaka Samhita (Chikitsa Sthana). Varanasi: Chaukhamba Sanskrit Sansthan; 2021. p.619.

Yadavji Trikamji Acharya. Charaka Samhita (Chikitsa Sthana). Varanasi: Chaukhamba Sanskrit Sansthan; 2021. p.626.

Yadavji Trikamji Acharya. Charaka Samhita (Vimana Sthana). Varanasi: Chaukhamba Sanskrit Sansthan; 2021. p.249.

Yadavji Trikamji Acharya. Charaka Samhita (Chikitsa Sthana). Varanasi: Chaukhamba Sanskrit Sansthan; 2021. p.626.

Yadavji Trikamji Acharya. Charaka Samhita (Sutrasthana). Varanasi: Chaukhamba Sanskrit Sansthan; 2021. p.79.

Yadavji Trikamji Acharya. Charaka Samhita (Sutrasthana). Varanasi: Chaukhamba Sanskrit Sansthan; 2021. p.174.

Yadavji Trikamji Acharya. Charaka Samhita (Chikitsa Sthana). Varanasi: Chaukhamba Sanskrit Sansthan; 2021. p.617.

Yadavji Trikamji Acharya. Charaka Samhita (Sutrasthana). Varanasi: Chaukhamba Sanskrit Sansthan; 2021. p.113.

Sri Madhavakara. Madhava Nidana. Varanasi: Chaukhamba Sanskrit Sansthan; 2012. p.6.

Yadavji Trikamji Acharya. Charaka Samhita (Chikitsa Sthana). Varanasi: Chaukhamba Sanskrit Sansthan; 2021. p.620.

Yadavji Trikamji Acharya. Charaka Samhita (Chikitsa Sthana). Varanasi: Chaukhamba Sanskrit Sansthan; 2021. p.627.

Guyton, A. C., & Hall, J. E. (2008). Textbook of Medical Physiology. Elsevier Saunders. p.185.

Guyton, A. C., & Hall, J. E. (2008). Textbook of Medical Physiology. Elsevier Saunders. p.165.

Picture courtesy: https://www.cvphysiology.com/Hemodynamics/H007

Guyton, A. C., & Hall, J. E. (2008). Textbook of Medical Physiology. Elsevier Saunders. p.281.

Yadavji Trikamji Acharya. Charaka Samhita (Chikitsa Sthana). Varanasi: Chaukhamba Sanskrit Sansthan; 1994. p.617.

Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005). The metabolic syndrome. The Lancet, 365(9468), 1415–1428. https://doi.org/10.1016/S0140-6736(05)66378-7

Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006). Metabolic syndrome—a new world-wide definition. Diabetic Medicine, 23(5), 469–480. https://doi.org/10.1111/j.1464-5491.2006.01858.x

Kahn, B. B., & Flier, J. S. (2000). Obesity and insulin resistance. The Journal of Clinical Investigation, 106(4), 473–481. https://doi.org/10.1172/JCI10842

Grundy, S. M. (2016). Metabolic syndrome update. Trends in Cardiovascular Medicine, 26(4), 364–373. https://doi.org/10.1016/j.tcm.2015.10.004

DeFronzo, R. A., & Ferrannini, E. (1991). Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14(3), 173–194. https://doi.org/10.2337/diacare.14.3.173

Krishnan, V. B., & Prashanth, A. S. (2018). Avarana and serum uric acid metabolism – A conceptual interpretation. Journal of Ayurveda and Integrated Medical Sciences, 4, 133–135. http://dx.doi.org/10.21760/jaims.v3i4.13297

Sumayya, P., & Vinod, D. S. (2021). Conceptual and clinical aspects of Avarana: A review. International Journal of Research in Ayurveda and Pharmacy, 12(4), 112–116. http://dx.doi.org/10.7897/2277-4343.12041164

Kalaskar, A., Garge, K., Chatufale, K., & Shinde, D. (n.d.). Study of correlation between Pittavruta Prana and acute gastritis. International Ayurvedic Medical Journal, 2488–2494.

Arjunrao, T. S., Dharmadhikari, B. D., & Amale, D. J. (n.d.). Understanding of Avarana W.S.R. to Pittavrutta Pran in Essential Hypertension. International Ayurvedic Medical Journal, 2356–2359.

Thakre, Y. J., Deshmukh, A. M., & Amale, D. J. (n.d.). Correlation study of Samana Avritta Apan & Irritable Bowel Syndrome. International Ayurvedic Medical Journal, 2568–2571.

Babu, R. R., & Jayakrishnan, P. G. (2020). An Agadatantra perspective of non-alcoholic fatty liver disease – A critical review. Journal of Emerging Technologies and Innovative Research, 7(7), 404–407.

CITATION
DOI: 10.21760/jaims.10.7.41
Published: 2025-08-07
How to Cite
1.
Garima Sisodiya, Rita Singh. A review study on the role of Avarana in the clinical presentation and pathogenesis of metabolic diseases. J Ayurveda Integr Med Sci [Internet]. 2025Aug.7 [cited 2025Aug.14];10(7):269 -276. Available from: https://www.jaims.in/jaims/article/view/4456
Section
Review Article